Related content

Positron Emission Tomography with 18-Fluorodeoxyglucose in the Staging and Follow-up of Lymphoma in the Chest

By Bangerter Markus   Kotzerke Jörg   Griesshammer Martin   Elsner Klaus   Reske Sven Norbert   Bergmann Lothar  

Acta Oncologica, Vol. 38, Iss. 6, 1999-09 ,pp. : 799-804

Informa Healthcare

Access to resources Recommend Favorite

Are 18 fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

By Maisey N.R.   Hill M.E.   Webb A.   Cunningham D.   Flux G.D.   Padhani A.   Ott R.J.   Norman A.   Bishop L.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 200-206

Elsevier

Access to resources Recommend Favorite

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [ 18 F]-fluorodeoxyglucose positron emission tomography

By Burcombe R.J.   Makris A.   Pittam M.   Lowe J.   Emmott J.   Wong W.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 375-379

Elsevier

Access to resources Recommend Favorite

Fluorodeoxyglucose positron emission tomography may aid the diagnosis of aggressive primary prostate cancer: A case series study

By          

Oncology Letters, Vol. 7, Iss. 2, 2014-01 ,pp. : 381-386

Spandidos Publications

Access to resources Recommend Favorite

Primary pulmonary amyloidosis misdiagnosed as malignancy on dual-timepoint fluoro-deoxyglucose positron emission tomography/computed tomography: A case report and review of the literature

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 591-594

Spandidos Publications

Access to resources Recommend Favorite